Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Zinc protoporphyrin binding to telomerase complexes and inhibition of telomerase activity.
Journal: Pharmacology research & perspectives
Published: September 22, 2021
Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders.
Journal: Journal of medical virology
Published: May 15, 2019
Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure-Activity Relationships.
Journal: Drug design, development and therapy
Published: January 10, 2019
Persisting risk of hepatocellular carcinoma after hepatitis C virus cure monitored by a liver transcriptome signature.
Journal: Hepatology (Baltimore, Md.)
Published: January 24, 2017
HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes.
Journal: PloS one
Published: March 10, 2016
Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.
Journal: Digestive diseases and sciences
Published: October 23, 2015
Finally sofosbuvir: an oral anti-HCV drug with wide performance capability.
Journal: Pharmacogenomics and personalized medicine
Published: December 26, 2014
Restoration of type I interferon expression by heme and related tetrapyrroles through inhibition of NS3/4A protease.
Journal: The Journal of infectious diseases
Published: August 01, 2013
Direct-acting antiviral agents and the path to interferon independence.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: March 27, 2013
Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin.
Journal: Journal of viral hepatitis
Published: June 13, 2012
Heme and HO-1 Inhibition of HCV, HBV, and HIV.
Journal: Frontiers in pharmacology
Published: February 15, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026